John Sterling

CDMO AGC Biologics signed a licensing agreement for Asimov’s off-the-shelf LV Edge Packaging cell line. AGC Biologics’ Cell and Gene Center of Excellence in Milan now offers a lentiviral packaging system that enables production from a single-plasmid trans... See more

Trenchant Biosystems released multiple internal and independent external data readouts for the prototype of its AutoCell CGT manufacturing platform. Company officials say they expect the AutoCell platform to reduce CGT vein-to-vein timelines from its curr... See more

Bionova Scientific, an Asahi Kasei CDMO, formed a manufacturing alliance with Syenex, a genetic medicines platform company, designed to expand global access to DNA plasmids for next-generation gene delivery for advanced cell and gene therapies. According ... See more

Aragen Biologics launched CHOMax™, a new cell line development and early manufacturing platform that the company says supports an integrated path from DNA to IND-enabling clinical supply for suitable standard IgG monoclonal antibodies. CHOMax has been ref... See more

Cellares and City of Hope, one of the largest cancer R&D treatment organizations in the U.S., said they will collaborate to evaluate automated manufacturing of City of Hope’s investigational gene-modified CAR T cell therapy targeting glioblastoma mult... See more